How Medical Practices Can Improve Collection Rates
Medical groups may need to address such issues as claims denials and failure to obtain prior authorization.
Medical groups may need to address such issues as claims denials and failure to obtain prior authorization.
In a phase 2b trial, around half of patients taking the novel calcineurin inhibitor at a dose of 23.7 mg twice daily achieved complete remission at 48 weeks.
In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis.
Among hemodialysis patients, sudden cardiac death accounted for 12% more cardiovascular-related mortalities in 2013 than in 2009.
Study documents an upswing in emergency department visits and observation stays.
Gout is uncontrolled in the majority of individuals with the condition, data show.